Anxiety, Depression and Quality of Life in Relation to SARS-CoV-2 Antibodies in Individuals Living with Diabetes During the Second Wave of COVID-19.
Alexander LindDhanisha Jayesh TrivediHesser HugoHårdstedt MariaStefan P O JanssonLernmark ÅkeSundqvist MartinStaffan TevellCheng-Ting TsaiJeanette WahlbergJohan H JendlePublished in: Diabetes epidemiology and management (2023)
A higher SARS-CoV-2 infection rate in T1D may be explained by younger age and higher employment rate, and the associated increased risk for viral exposure.